Waiv
Paris, France
Waiv is a healthcare startup focused on catalyzing precision medicine through AI-enabled diagnostics in digital pathology. Leveraging over seven years of medical AI research, Waiv develops transformative tests that enhance biomarker discovery and optimize diagnostic workflows, making precision oncology accessible to patients globally. Waiv's products include clinically validated AI tests like RlapsRisk BC, designed to provide morphological insights that improve clinical diagnostic processes. Collaborating with leading medical institutions, Waiv aims to address the complexities and costs associated with biomarker testing as part of the broader shift towards precision care.
Company Info
- Founded
- 2024
- Website
- waiv.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Waiv?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment